Europe Nutraceutical Excipients Market, By Type (Flavoring Agents, Coloring Agents, Sweeteners, Coating Agent, Buffers, Solvents, Carriers, Antifoams, Gliding Agents, Wetting Agents, Thickeners/ Gelling Agents, Preservatives, Binders, Disintegrates, Lubricants, Fillers and Diluents and Others), End Product (Prebiotics, Probiotics, Protein and Amino Acid Supplements, Mineral Supplements, Vitamin Supplements, Omega-3 Supplements and Other Supplements), Form (Dry and liquid), Excipient Source (Natural and Synthetic), Distribution Channel (Direct Tender, Retail Sales and Others) - Industry Trends and Forecast to 2030.
Europe Nutraceutical Excipients Market Analysis and Size
Nutraceutical excipients play a major role in drug formulation and its development. These substances involve substances other than the pharmacologically active drug or prodrug. Nutraceutical excipients provide the drug with efficient drug delivery to the target site. These molecules prevent the drug from being released too early while assimilation and enhancing the drug's efficacy. Some nutraceutical excipients promote drug integration, which boosts drug absorption in the bloodstream.
Data Bridge Market Research analyzes that the Europe nutraceutical excipients market is expected to reach the value of USD 774.81 million by 2030, at a CAGR of 7.3% during the forecast period. Binders account for the largest segment in the market due to the rapid demand globally. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2020-2015)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Flavoring Agents, Coloring Agents, Sweeteners, Coating Agent, Buffers, Solvents, Carriers, Antifoams, Gliding Agents, Wetting Agents, Thickeners/ Gelling Agents, Preservatives, Binders, Disintegrates, Lubricants, Fillers and Diluents and Others), End Product (Prebiotics, Probiotics, Protein and Amino Acid Supplements, Mineral Supplements, Vitamin Supplements, Omega-3 Supplements and Other Supplements), Form (Dry and liquid), Excipient Source (Natural and Synthetic), Distribution Channel (Direct Tender, Retail Sales and Others)
|
|
Countries Covered
|
Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, Rest of Europe
|
|
Market Players Covered
|
BASF SE., DuPont, Ingredion Incorporated, W.R Grace and Co, Kerry Group, Sensient Technologies, Roquette Pharma Solutions, Cargill, Ashland. SEPPIC, Gatefosse, Pioma Chemicals, Omya., Gangwal Chemicals Private Limited, Grain Processing Corporation, IMCD Group., JRS Pharma LP, Azelis, Jigs Chemical, Sigaichi Industries, Beneo and Abitec, among others.
|
Market Definition
Nutraceutical excipients involve everything in a drug except the active nutraceutical ingredients. These molecules don’t possess any medicinal properties and are ultimately used for enhancing the physiological absorption of the drug. Nutraceutical excipients are inert in nature, allowing the drug molecule to apply to patients in the right form. Traditionally, nutraceutical excipients were simple molecules, but the innovation in technology and increasing demand for novel drug delivery systems enhanced the nutraceutical excipients' complexity. Nutraceutical excipients promote the patient’s drug acceptability and boost the drug's stability and bioavailability.
The future of excipients science and technology has changed and continues to change. Better progress has been made in such areas as the harmonization of excipient monographs and the application of new analytical methods to better characterize excipients.
Europe Nutraceutical Excipients Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail below:
Drivers
- INCREASING AWARENESS REGARDING NUTRACEUTICAL APPLICATIONS
Nutraceutical is derived from nutritional and pharmaceutical. Nutraceutical excipients, also known as ‘functional foods,’ are inactive components prepared with Active Pharmaceutical Ingredients (API) for bulking up solutions with powerful active ingredients. These nutraceutical excipients are used in standardized and pharmaceutical-grade supplements. The skyrocketing increase in medical costs has, affected the nutraceutical excipient market significantly. Excipients are inert substances, other than active drugs, introduced into the manufacturing process or included in the dosage form of nutraceutical products. Excipients are widely used in drug formulations to add bulk to solid formulations, provide long-term stability and facilitate drug absorption. Furthermore, it also improves the overall safety and functional properties of the product during use or storage. The large and diversified application of excipients has made them a very common household name.
Thus, wide applications of nutraceuticals in chronic disease treatment are surging demand for excipients in the Europe nutraceutical excipients market.
- TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
Multifunctional excipients are a class of excipients that includes pre-processed and co-processed excipients that provide added functionalities to the formulation. The enhanced functionality includes flowability, compressibility, particle size distribution, shape and porosity, among others.
The recent interest in demanding manufacturing processes and the focus on alternative delivery systems has led to increased demand for a range of specialty excipients collectively known as multifunctional excipients. The nanotechnology-enabled drug delivery systems are used to cater to the issue of drug toxicity. There are two major approaches to using nanotechnology as a drug delivery system, such as reducing the size of nutraceutical drug crystals to ensure enhanced solubility and bioavailability and using some form of nano-carrier for effective delivery of active ingredients.
Restraint
- Increasing Regulatory Stringency Regarding the Approval of Drugs and Excipients
Generic drug approval rules are largely the same worldwide, with little difference in developing countries. Governments must ensure the consistent quality of all generic drugs. A major reason for physicians' (and even patients') lack of confidence in generic drugs has been the lack of strict regulatory requirements regarding the number of generic drugs and the number of impurities allowed.
Thus, a rise in regulatory stringency regarding the approval of excipients and drugs is expected to restrain the Europe nutraceutical excipients market.
Opportunity
-
Increasing demands for alternative routes of delivery and dosage forms
Nutraceuticals are derived from the words nutritional and pharmaceutical. Nutraceutical excipients are inactive components prepared with Active Pharmaceutical Ingredients (API) for bulking up solutions containing potent active ingredients. These nutraceutical excipients are found in supplements that are standardized and pharmaceutical grade.
The development of new treatments or preventive supplements like nutraceuticals for chronic diseases, increased access to medication through generic drug production and increased research and development spending is the major factor for which the alternative routes are a boost.
The advancement in the novel drug delivery system (NDDS) and alternative dosage formulation and route of administration are expected to increase the demand for the new excipient and act as an opportunity for market growth.
Challenge
- Associated Side effects with nutraceutical excipients:
Most of the nutraceuticals contain excipients. They are added for several purposes. They can improve product performance, including enabling formulations, the patient's acceptance and compliance, or providing a more effective and safe drug, such as modified release formulations or taste-masked syrups for children.
Nutraceutical Excipients are not always the inert substances that we presume. They are intolerant to an individual or, if not properly screened, can cause chemical changes in the drug, causing the side-effect. This can affect the demand for the excipient and is expected to act as a challenge for the market.
Post-COVID-19 Impact on the Europe Nutraceutical Excipients Market
The nutraceutical industry has been severely affected by the COVID-19 pandemic. Lockdowns imposed due to the epidemic have disrupted the supply of raw materials from manufacturing centers such as India and China. This slowed drug development and production, severely affecting companies that relied heavily on outsourcing. Initially, the entire nutraceutical ecosystem was disrupted. In addition, regulatory agencies had to draft and draft new laws to ensure maximum patient safety after using drugs. After the shutdowns ended, the nutraceutical industry gained steam, especially due to the demand for drugs such as hydroxychloroquine and Remdesivir, which showed positive results against COVID-19. The growing demand for these drugs boosted the turnover of some companies.
Recent Developments
- In February 2022, Kerry Group Plc., the world’s leading taste and Nutrition Company, announced that it had made two significant biotechnology acquisitions that have expanded its expertise, technology portfolio and manufacturing capabilities. The company has announced that it has acquired the leading biotechnology Innovation Company, c-LEcta and Mexican-based enzyme manufacturer, Enmex. c-LEcta is a leading biotechnology innovation company specializing in precision fermentation, optimized bio-processing and bio-transformation. Also, Enmex is a well-established enzyme manufacturer based in Mexico, supplying multiple bio-process solutions for food, beverage and animal nutrition markets. This has helped the company to increase its revenue
- In September 2022, DFE Pharma, a Europe leader in pharma- and nutraceutical excipient solutions, opened its new “Closer to the Formulator” (C2F), a Center of Excellence, in Hyderabad, India. C2F helped pharmaceutical companies to shorten the time from concept to finished commercial product through its expertise in all phases of pharmaceutical development. This has helped the company to showcase its progress
Europe Nutraceutical Excipients Market Scope
The Europe nutraceutical excipients market is segmented into type, end products, form, excipient source and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE
- BINDERS
- FILLERS AND DILUENTS
- DISINTEGRANTS
- COATING MATERIAL
- COLORING AGENTS
- FLAVORING AGENTS
- SWEETENERS
- LUBRICANTS
- BUFFERS
- PRESERVATIVES
- THICKENERS/GELLING AGENTS
- WETTING AGENTS
- GLIDING AGENTS
- SOLVENTS
- CARRIERS
- ANTIFOAMS
- OTHERS
On the basis of type, the Europe nutraceutical excipients market is segmented into Flavoring Agents, Coloring Agents, Sweeteners, Coating Agent, Buffers, Solvents, Carriers, Antifoams, Gliding Agents, Wetting Agents, Thickeners/ Gelling Agents, Preservatives, Binders, Disintegrates, Lubricants, Fillers and Diluents and others.
EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCTS
- BINDERS
- FILLERS AND DILUENTS
- DISINTEGRATES
- COATING MATERIAL
- COLORING AGENTS
- FLAVORING AGENTS
- SWEETENERS
- LUBRICANTS
- BUFFERS
- PRESERVATIVES
- THICKENERS/GELLING AGENTS
- WETTING AGENTS
- GLIDING AGENTS
- SOLVENTS
- CARRIERS
- ANTIFOAMS
- OTHERS
On the basis of end products, the Europe nutraceutical excipients market is segmented into prebiotics by excipients, probiotics by excipients, protein and amino acid supplements by excipients, mineral supplements by excipients, vitamin supplements, omega-3 supplements by excipients and other supplements.
EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM
- DRY
- LIQUID
On the basis of form, the Europe nutraceutical excipients market is segmented into dry and liquid.
EUROPE NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE
- NATURAL
- SYNTHETIC
On the basis of excipients source, the Europe nutraceutical excipients market is segmented into natural and synthetic.
EUROPE PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL SALES
- OTHERS
On the basis of distribution channel, the Europe nutraceutical excipients market is segmented into direct tender, retail sales and others.
Europe Nutraceutical Excipients Market Regional Analysis/Insights
The Europe nutraceutical excipients market is analyzed and market size information is provided type, end products, form, excipient source and distribution channel.
The countries covered in this market report are Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, and Rest of Europe.
Germany is dominating due to the presence of key market players in the largest consumer market with high GDP.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Nutraceutical Excipients Market Share Analysis
Europe nutraceutical excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe nutraceutical excipients market.
Some of the major players operating in the Europe nutraceutical excipients market are BASF SE., DuPont, Ingredion Incorporated, W.R Grace and Co, Kerry Group, Sensient Technologies, Roquette Pharma Solutions, Cargill, Ashland. SEPPIC, Gatefosse, Pioma Chemicals, Omya., Gangwal Chemicals Private Limited, Grain Processing Corporation, IMCD Group., JRS Pharma LP, Azelis, Jigs Chemical, Sigaichi Industries, Beneo and Abitec, among others.
SKU-